Biosimilar Development
4 FOLLOWERS
The Biosimilar Development community is not made up of generalists. They're specialists, like us. We deliver in-depth content from authoritative authors and sources because that's what our community demands. Our goal is to be the most valuable resource for a specific segment of the industry - biosimilars - and the professionals who make their living there.
Biosimilar Development
1w ago
Explore how ADC chemistry and manufacturing have evolved, the challenges this dynamic growth has created, and how CDMOs are adapting to these changes to meet customer needs, now and in the future ..read more
Biosimilar Development
3w ago
Learn about the recirculation and perfusion processes made possible by single-use, fixed-bed bioreactors designed for scaling up adherent cell culture processes ..read more
Biosimilar Development
3w ago
Discover how insights into cell metabolism can further enable the development of efficient cell culture processes through tailored nutrient supplementation and monitoring ..read more
Biosimilar Development
1M ago
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption ..read more
Biosimilar Development
1M ago
Explore how one organization built upon 15+ years of experience and an extensive knowledge base of biologics manufacturing to establish commercial-scale ADC manufacturing capabilities ..read more
Biosimilar Development
3M ago
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development ..read more
Biosimilar Development
3M ago
The presence of anti-drug antibodies (ADAs) can affect the effectiveness and safety of biologic drugs. Read why regulatory agencies emphasize the need for extensive immunogenicity evaluation in biosimilar development ..read more
Biosimilar Development
3M ago
Discover the impact revised pharmaceutical legislation will have on the industry by superseding regulations that have fostered the availability of safe and effective medicines for the past two decades ..read more
Biosimilar Development
3M ago
Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization ..read more
Biosimilar Development
3M ago
Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future ..read more